Molecular targeting therapy targeting for inhibition of metastasis on oral squamous cell carcinoma
Project/Area Number |
22791972
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Single-year Grants |
Research Field |
Surgical dentistry
|
Research Institution | Osaka University |
Principal Investigator |
|
Project Period (FY) |
2010 – 2011
|
Project Status |
Completed (Fiscal Year 2011)
|
Budget Amount *help |
¥3,380,000 (Direct Cost: ¥2,600,000、Indirect Cost: ¥780,000)
Fiscal Year 2011: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2010: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | 口腔癌 / 分子標的治療 |
Research Abstract |
An important tool of cancer therapy in 21th century is a molecular targeting therapy. However there are a little studies to focused on distant metastasis and lymph node metastasis which occur frequently on oral squamous cell carcinoma. Combinations of safingol, which induced apoptosis caspase independent manner and GGTI-298, new molecular target drug, exhibited synergistic effect. GGTI-298 and safingol inhibited cell growth synergistically and increased the number of apoptotic cells. Combination of safingol and GGTI-298 may be a candidate for the treatment of oral SCC targeting for anticancer drug resistance and suppression of metastasis because safingol have antitumor effect and GGTI-298 suppress metastasis.
|
Report
(3 results)
Research Products
(13 results)